Medical Devices & Consumables
Global On-body Injectors Market Research Report 2025
- Aug 11, 25
- ID: 121519
- Pages: 95
- Figures: 91
- Views: 12
Report Scope
This report aims to provide a comprehensive presentation of the global market for On-body Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding On-body Injectors.
The On-body Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global On-body Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the On-body Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
MicroMED
Altek Medical
Segment by Type
Electronic Injectors
Mechanical Injectors
Segment by Application
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of On-body Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of On-body Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for On-body Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding On-body Injectors.
The On-body Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global On-body Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the On-body Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
MicroMED
Altek Medical
Segment by Type
Electronic Injectors
Mechanical Injectors
Segment by Application
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of On-body Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of On-body Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 On-body Injectors Market Overview
1.1 Product Definition
1.2 On-body Injectors by Type
1.2.1 Global On-body Injectors Market Value Comparison by Type (2024 VS 2031)
1.2.2 Electronic Injectors
1.2.3 Mechanical Injectors
1.3 On-body Injectors by Application
1.3.1 Global On-body Injectors Market Value by Application (2024 VS 2031)
1.3.2 Immuno-oncology
1.3.3 Cardiovascular Diseases
1.3.4 Neurological Diseases
1.3.5 Others
1.4 Global On-body Injectors Market Size Estimates and Forecasts
1.4.1 Global On-body Injectors Revenue 2020-2031
1.4.2 Global On-body Injectors Sales 2020-2031
1.4.3 Global On-body Injectors Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 On-body Injectors Market Competition by Manufacturers
2.1 Global On-body Injectors Sales Market Share by Manufacturers (2020-2025)
2.2 Global On-body Injectors Revenue Market Share by Manufacturers (2020-2025)
2.3 Global On-body Injectors Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of On-body Injectors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of On-body Injectors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of On-body Injectors, Product Type & Application
2.7 Global Key Manufacturers of On-body Injectors, Date of Enter into This Industry
2.8 Global On-body Injectors Market Competitive Situation and Trends
2.8.1 Global On-body Injectors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest On-body Injectors Players Market Share by Revenue
2.8.3 Global On-body Injectors Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global On-body Injectors Market Scenario by Region
3.1 Global On-body Injectors Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global On-body Injectors Sales by Region: 2020-2031
3.2.1 Global On-body Injectors Sales by Region: 2020-2025
3.2.2 Global On-body Injectors Sales by Region: 2026-2031
3.3 Global On-body Injectors Revenue by Region: 2020-2031
3.3.1 Global On-body Injectors Revenue by Region: 2020-2025
3.3.2 Global On-body Injectors Revenue by Region: 2026-2031
3.4 North America On-body Injectors Market Facts & Figures by Country
3.4.1 North America On-body Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America On-body Injectors Sales by Country (2020-2031)
3.4.3 North America On-body Injectors Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe On-body Injectors Market Facts & Figures by Country
3.5.1 Europe On-body Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe On-body Injectors Sales by Country (2020-2031)
3.5.3 Europe On-body Injectors Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific On-body Injectors Market Facts & Figures by Region
3.6.1 Asia Pacific On-body Injectors Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific On-body Injectors Sales by Region (2020-2031)
3.6.3 Asia Pacific On-body Injectors Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America On-body Injectors Market Facts & Figures by Country
3.7.1 Latin America On-body Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America On-body Injectors Sales by Country (2020-2031)
3.7.3 Latin America On-body Injectors Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa On-body Injectors Market Facts & Figures by Country
3.8.1 Middle East and Africa On-body Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa On-body Injectors Sales by Country (2020-2031)
3.8.3 Middle East and Africa On-body Injectors Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global On-body Injectors Sales by Type (2020-2031)
4.1.1 Global On-body Injectors Sales by Type (2020-2025)
4.1.2 Global On-body Injectors Sales by Type (2026-2031)
4.1.3 Global On-body Injectors Sales Market Share by Type (2020-2031)
4.2 Global On-body Injectors Revenue by Type (2020-2031)
4.2.1 Global On-body Injectors Revenue by Type (2020-2025)
4.2.2 Global On-body Injectors Revenue by Type (2026-2031)
4.2.3 Global On-body Injectors Revenue Market Share by Type (2020-2031)
4.3 Global On-body Injectors Price by Type (2020-2031)
5 Segment by Application
5.1 Global On-body Injectors Sales by Application (2020-2031)
5.1.1 Global On-body Injectors Sales by Application (2020-2025)
5.1.2 Global On-body Injectors Sales by Application (2026-2031)
5.1.3 Global On-body Injectors Sales Market Share by Application (2020-2031)
5.2 Global On-body Injectors Revenue by Application (2020-2031)
5.2.1 Global On-body Injectors Revenue by Application (2020-2025)
5.2.2 Global On-body Injectors Revenue by Application (2026-2031)
5.2.3 Global On-body Injectors Revenue Market Share by Application (2020-2031)
5.3 Global On-body Injectors Price by Application (2020-2031)
6 Key Companies Profiled
6.1 West Pharmaceutical Services
6.1.1 West Pharmaceutical Services Company Information
6.1.2 West Pharmaceutical Services Description and Business Overview
6.1.3 West Pharmaceutical Services On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.1.4 West Pharmaceutical Services On-body Injectors Product Portfolio
6.1.5 West Pharmaceutical Services Recent Developments/Updates
6.2 Insulet
6.2.1 Insulet Company Information
6.2.2 Insulet Description and Business Overview
6.2.3 Insulet On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Insulet On-body Injectors Product Portfolio
6.2.5 Insulet Recent Developments/Updates
6.3 Gerresheimer
6.3.1 Gerresheimer Company Information
6.3.2 Gerresheimer Description and Business Overview
6.3.3 Gerresheimer On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gerresheimer On-body Injectors Product Portfolio
6.3.5 Gerresheimer Recent Developments/Updates
6.4 United Therapeutics
6.4.1 United Therapeutics Company Information
6.4.2 United Therapeutics Description and Business Overview
6.4.3 United Therapeutics On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 United Therapeutics On-body Injectors Product Portfolio
6.4.5 United Therapeutics Recent Developments/Updates
6.5 CC Bio
6.5.1 CC Bio Company Information
6.5.2 CC Bio Description and Business Overview
6.5.3 CC Bio On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CC Bio On-body Injectors Product Portfolio
6.5.5 CC Bio Recent Developments/Updates
6.6 BD
6.6.1 BD Company Information
6.6.2 BD Description and Business Overview
6.6.3 BD On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BD On-body Injectors Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 Ypsomed
6.7.1 Ypsomed Company Information
6.7.2 Ypsomed Description and Business Overview
6.7.3 Ypsomed On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ypsomed On-body Injectors Product Portfolio
6.7.5 Ypsomed Recent Developments/Updates
6.8 Enable Injections
6.8.1 Enable Injections Company Information
6.8.2 Enable Injections Description and Business Overview
6.8.3 Enable Injections On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Enable Injections On-body Injectors Product Portfolio
6.8.5 Enable Injections Recent Developments/Updates
6.9 Nemera
6.9.1 Nemera Company Information
6.9.2 Nemera Description and Business Overview
6.9.3 Nemera On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Nemera On-body Injectors Product Portfolio
6.9.5 Nemera Recent Developments/Updates
6.10 Stevanato Group
6.10.1 Stevanato Group Company Information
6.10.2 Stevanato Group Description and Business Overview
6.10.3 Stevanato Group On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Stevanato Group On-body Injectors Product Portfolio
6.10.5 Stevanato Group Recent Developments/Updates
6.11 Sonceboz
6.11.1 Sonceboz Company Information
6.11.2 Sonceboz Description and Business Overview
6.11.3 Sonceboz On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sonceboz On-body Injectors Product Portfolio
6.11.5 Sonceboz Recent Developments/Updates
6.12 Lohmann Therapie-Systeme
6.12.1 Lohmann Therapie-Systeme Company Information
6.12.2 Lohmann Therapie-Systeme Description and Business Overview
6.12.3 Lohmann Therapie-Systeme On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Lohmann Therapie-Systeme On-body Injectors Product Portfolio
6.12.5 Lohmann Therapie-Systeme Recent Developments/Updates
6.13 Elcam Drug Delivery Devices (E3D)
6.13.1 Elcam Drug Delivery Devices (E3D) Company Information
6.13.2 Elcam Drug Delivery Devices (E3D) Description and Business Overview
6.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Portfolio
6.13.5 Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
6.14 MicroMED
6.14.1 MicroMED Company Information
6.14.2 MicroMED Description and Business Overview
6.14.3 MicroMED On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.14.4 MicroMED On-body Injectors Product Portfolio
6.14.5 MicroMED Recent Developments/Updates
6.15 Altek Medical
6.15.1 Altek Medical Company Information
6.15.2 Altek Medical Description and Business Overview
6.15.3 Altek Medical On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Altek Medical On-body Injectors Product Portfolio
6.15.5 Altek Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 On-body Injectors Industry Chain Analysis
7.2 On-body Injectors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 On-body Injectors Production Mode & Process Analysis
7.4 On-body Injectors Sales and Marketing
7.4.1 On-body Injectors Sales Channels
7.4.2 On-body Injectors Distributors
7.5 On-body Injectors Customer Analysis
8 On-body Injectors Market Dynamics
8.1 On-body Injectors Industry Trends
8.2 On-body Injectors Market Drivers
8.3 On-body Injectors Market Challenges
8.4 On-body Injectors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 On-body Injectors by Type
1.2.1 Global On-body Injectors Market Value Comparison by Type (2024 VS 2031)
1.2.2 Electronic Injectors
1.2.3 Mechanical Injectors
1.3 On-body Injectors by Application
1.3.1 Global On-body Injectors Market Value by Application (2024 VS 2031)
1.3.2 Immuno-oncology
1.3.3 Cardiovascular Diseases
1.3.4 Neurological Diseases
1.3.5 Others
1.4 Global On-body Injectors Market Size Estimates and Forecasts
1.4.1 Global On-body Injectors Revenue 2020-2031
1.4.2 Global On-body Injectors Sales 2020-2031
1.4.3 Global On-body Injectors Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 On-body Injectors Market Competition by Manufacturers
2.1 Global On-body Injectors Sales Market Share by Manufacturers (2020-2025)
2.2 Global On-body Injectors Revenue Market Share by Manufacturers (2020-2025)
2.3 Global On-body Injectors Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of On-body Injectors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of On-body Injectors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of On-body Injectors, Product Type & Application
2.7 Global Key Manufacturers of On-body Injectors, Date of Enter into This Industry
2.8 Global On-body Injectors Market Competitive Situation and Trends
2.8.1 Global On-body Injectors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest On-body Injectors Players Market Share by Revenue
2.8.3 Global On-body Injectors Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global On-body Injectors Market Scenario by Region
3.1 Global On-body Injectors Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global On-body Injectors Sales by Region: 2020-2031
3.2.1 Global On-body Injectors Sales by Region: 2020-2025
3.2.2 Global On-body Injectors Sales by Region: 2026-2031
3.3 Global On-body Injectors Revenue by Region: 2020-2031
3.3.1 Global On-body Injectors Revenue by Region: 2020-2025
3.3.2 Global On-body Injectors Revenue by Region: 2026-2031
3.4 North America On-body Injectors Market Facts & Figures by Country
3.4.1 North America On-body Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America On-body Injectors Sales by Country (2020-2031)
3.4.3 North America On-body Injectors Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe On-body Injectors Market Facts & Figures by Country
3.5.1 Europe On-body Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe On-body Injectors Sales by Country (2020-2031)
3.5.3 Europe On-body Injectors Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific On-body Injectors Market Facts & Figures by Region
3.6.1 Asia Pacific On-body Injectors Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific On-body Injectors Sales by Region (2020-2031)
3.6.3 Asia Pacific On-body Injectors Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America On-body Injectors Market Facts & Figures by Country
3.7.1 Latin America On-body Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America On-body Injectors Sales by Country (2020-2031)
3.7.3 Latin America On-body Injectors Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa On-body Injectors Market Facts & Figures by Country
3.8.1 Middle East and Africa On-body Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa On-body Injectors Sales by Country (2020-2031)
3.8.3 Middle East and Africa On-body Injectors Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global On-body Injectors Sales by Type (2020-2031)
4.1.1 Global On-body Injectors Sales by Type (2020-2025)
4.1.2 Global On-body Injectors Sales by Type (2026-2031)
4.1.3 Global On-body Injectors Sales Market Share by Type (2020-2031)
4.2 Global On-body Injectors Revenue by Type (2020-2031)
4.2.1 Global On-body Injectors Revenue by Type (2020-2025)
4.2.2 Global On-body Injectors Revenue by Type (2026-2031)
4.2.3 Global On-body Injectors Revenue Market Share by Type (2020-2031)
4.3 Global On-body Injectors Price by Type (2020-2031)
5 Segment by Application
5.1 Global On-body Injectors Sales by Application (2020-2031)
5.1.1 Global On-body Injectors Sales by Application (2020-2025)
5.1.2 Global On-body Injectors Sales by Application (2026-2031)
5.1.3 Global On-body Injectors Sales Market Share by Application (2020-2031)
5.2 Global On-body Injectors Revenue by Application (2020-2031)
5.2.1 Global On-body Injectors Revenue by Application (2020-2025)
5.2.2 Global On-body Injectors Revenue by Application (2026-2031)
5.2.3 Global On-body Injectors Revenue Market Share by Application (2020-2031)
5.3 Global On-body Injectors Price by Application (2020-2031)
6 Key Companies Profiled
6.1 West Pharmaceutical Services
6.1.1 West Pharmaceutical Services Company Information
6.1.2 West Pharmaceutical Services Description and Business Overview
6.1.3 West Pharmaceutical Services On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.1.4 West Pharmaceutical Services On-body Injectors Product Portfolio
6.1.5 West Pharmaceutical Services Recent Developments/Updates
6.2 Insulet
6.2.1 Insulet Company Information
6.2.2 Insulet Description and Business Overview
6.2.3 Insulet On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Insulet On-body Injectors Product Portfolio
6.2.5 Insulet Recent Developments/Updates
6.3 Gerresheimer
6.3.1 Gerresheimer Company Information
6.3.2 Gerresheimer Description and Business Overview
6.3.3 Gerresheimer On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gerresheimer On-body Injectors Product Portfolio
6.3.5 Gerresheimer Recent Developments/Updates
6.4 United Therapeutics
6.4.1 United Therapeutics Company Information
6.4.2 United Therapeutics Description and Business Overview
6.4.3 United Therapeutics On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 United Therapeutics On-body Injectors Product Portfolio
6.4.5 United Therapeutics Recent Developments/Updates
6.5 CC Bio
6.5.1 CC Bio Company Information
6.5.2 CC Bio Description and Business Overview
6.5.3 CC Bio On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CC Bio On-body Injectors Product Portfolio
6.5.5 CC Bio Recent Developments/Updates
6.6 BD
6.6.1 BD Company Information
6.6.2 BD Description and Business Overview
6.6.3 BD On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BD On-body Injectors Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 Ypsomed
6.7.1 Ypsomed Company Information
6.7.2 Ypsomed Description and Business Overview
6.7.3 Ypsomed On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ypsomed On-body Injectors Product Portfolio
6.7.5 Ypsomed Recent Developments/Updates
6.8 Enable Injections
6.8.1 Enable Injections Company Information
6.8.2 Enable Injections Description and Business Overview
6.8.3 Enable Injections On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Enable Injections On-body Injectors Product Portfolio
6.8.5 Enable Injections Recent Developments/Updates
6.9 Nemera
6.9.1 Nemera Company Information
6.9.2 Nemera Description and Business Overview
6.9.3 Nemera On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Nemera On-body Injectors Product Portfolio
6.9.5 Nemera Recent Developments/Updates
6.10 Stevanato Group
6.10.1 Stevanato Group Company Information
6.10.2 Stevanato Group Description and Business Overview
6.10.3 Stevanato Group On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Stevanato Group On-body Injectors Product Portfolio
6.10.5 Stevanato Group Recent Developments/Updates
6.11 Sonceboz
6.11.1 Sonceboz Company Information
6.11.2 Sonceboz Description and Business Overview
6.11.3 Sonceboz On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sonceboz On-body Injectors Product Portfolio
6.11.5 Sonceboz Recent Developments/Updates
6.12 Lohmann Therapie-Systeme
6.12.1 Lohmann Therapie-Systeme Company Information
6.12.2 Lohmann Therapie-Systeme Description and Business Overview
6.12.3 Lohmann Therapie-Systeme On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Lohmann Therapie-Systeme On-body Injectors Product Portfolio
6.12.5 Lohmann Therapie-Systeme Recent Developments/Updates
6.13 Elcam Drug Delivery Devices (E3D)
6.13.1 Elcam Drug Delivery Devices (E3D) Company Information
6.13.2 Elcam Drug Delivery Devices (E3D) Description and Business Overview
6.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Portfolio
6.13.5 Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
6.14 MicroMED
6.14.1 MicroMED Company Information
6.14.2 MicroMED Description and Business Overview
6.14.3 MicroMED On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.14.4 MicroMED On-body Injectors Product Portfolio
6.14.5 MicroMED Recent Developments/Updates
6.15 Altek Medical
6.15.1 Altek Medical Company Information
6.15.2 Altek Medical Description and Business Overview
6.15.3 Altek Medical On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Altek Medical On-body Injectors Product Portfolio
6.15.5 Altek Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 On-body Injectors Industry Chain Analysis
7.2 On-body Injectors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 On-body Injectors Production Mode & Process Analysis
7.4 On-body Injectors Sales and Marketing
7.4.1 On-body Injectors Sales Channels
7.4.2 On-body Injectors Distributors
7.5 On-body Injectors Customer Analysis
8 On-body Injectors Market Dynamics
8.1 On-body Injectors Industry Trends
8.2 On-body Injectors Market Drivers
8.3 On-body Injectors Market Challenges
8.4 On-body Injectors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global On-body Injectors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global On-body Injectors Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global On-body Injectors Market Competitive Situation by Manufacturers in 2024
Table 4. Global On-body Injectors Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global On-body Injectors Sales Market Share by Manufacturers (2020-2025)
Table 6. Global On-body Injectors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global On-body Injectors Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market On-body Injectors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of On-body Injectors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of On-body Injectors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of On-body Injectors, Product Type & Application
Table 12. Global Key Manufacturers of On-body Injectors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global On-body Injectors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in On-body Injectors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global On-body Injectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global On-body Injectors Sales by Region (2020-2025) & (K Units)
Table 18. Global On-body Injectors Sales Market Share by Region (2020-2025)
Table 19. Global On-body Injectors Sales by Region (2026-2031) & (K Units)
Table 20. Global On-body Injectors Sales Market Share by Region (2026-2031)
Table 21. Global On-body Injectors Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global On-body Injectors Revenue Market Share by Region (2020-2025)
Table 23. Global On-body Injectors Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global On-body Injectors Revenue Market Share by Region (2026-2031)
Table 25. North America On-body Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America On-body Injectors Sales by Country (2020-2025) & (K Units)
Table 27. North America On-body Injectors Sales by Country (2026-2031) & (K Units)
Table 28. North America On-body Injectors Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America On-body Injectors Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe On-body Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe On-body Injectors Sales by Country (2020-2025) & (K Units)
Table 32. Europe On-body Injectors Sales by Country (2026-2031) & (K Units)
Table 33. Europe On-body Injectors Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe On-body Injectors Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific On-body Injectors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific On-body Injectors Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific On-body Injectors Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific On-body Injectors Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific On-body Injectors Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America On-body Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America On-body Injectors Sales by Country (2020-2025) & (K Units)
Table 42. Latin America On-body Injectors Sales by Country (2026-2031) & (K Units)
Table 43. Latin America On-body Injectors Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America On-body Injectors Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa On-body Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa On-body Injectors Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa On-body Injectors Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa On-body Injectors Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa On-body Injectors Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global On-body Injectors Sales (K Units) by Type (2020-2025)
Table 51. Global On-body Injectors Sales (K Units) by Type (2026-2031)
Table 52. Global On-body Injectors Sales Market Share by Type (2020-2025)
Table 53. Global On-body Injectors Sales Market Share by Type (2026-2031)
Table 54. Global On-body Injectors Revenue (US$ Million) by Type (2020-2025)
Table 55. Global On-body Injectors Revenue (US$ Million) by Type (2026-2031)
Table 56. Global On-body Injectors Revenue Market Share by Type (2020-2025)
Table 57. Global On-body Injectors Revenue Market Share by Type (2026-2031)
Table 58. Global On-body Injectors Price (US$/Unit) by Type (2020-2025)
Table 59. Global On-body Injectors Price (US$/Unit) by Type (2026-2031)
Table 60. Global On-body Injectors Sales (K Units) by Application (2020-2025)
Table 61. Global On-body Injectors Sales (K Units) by Application (2026-2031)
Table 62. Global On-body Injectors Sales Market Share by Application (2020-2025)
Table 63. Global On-body Injectors Sales Market Share by Application (2026-2031)
Table 64. Global On-body Injectors Revenue (US$ Million) by Application (2020-2025)
Table 65. Global On-body Injectors Revenue (US$ Million) by Application (2026-2031)
Table 66. Global On-body Injectors Revenue Market Share by Application (2020-2025)
Table 67. Global On-body Injectors Revenue Market Share by Application (2026-2031)
Table 68. Global On-body Injectors Price (US$/Unit) by Application (2020-2025)
Table 69. Global On-body Injectors Price (US$/Unit) by Application (2026-2031)
Table 70. West Pharmaceutical Services Company Information
Table 71. West Pharmaceutical Services Description and Business Overview
Table 72. West Pharmaceutical Services On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. West Pharmaceutical Services On-body Injectors Product
Table 74. West Pharmaceutical Services Recent Developments/Updates
Table 75. Insulet Company Information
Table 76. Insulet Description and Business Overview
Table 77. Insulet On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Insulet On-body Injectors Product
Table 79. Insulet Recent Developments/Updates
Table 80. Gerresheimer Company Information
Table 81. Gerresheimer Description and Business Overview
Table 82. Gerresheimer On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Gerresheimer On-body Injectors Product
Table 84. Gerresheimer Recent Developments/Updates
Table 85. United Therapeutics Company Information
Table 86. United Therapeutics Description and Business Overview
Table 87. United Therapeutics On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. United Therapeutics On-body Injectors Product
Table 89. United Therapeutics Recent Developments/Updates
Table 90. CC Bio Company Information
Table 91. CC Bio Description and Business Overview
Table 92. CC Bio On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. CC Bio On-body Injectors Product
Table 94. CC Bio Recent Developments/Updates
Table 95. BD Company Information
Table 96. BD Description and Business Overview
Table 97. BD On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. BD On-body Injectors Product
Table 99. BD Recent Developments/Updates
Table 100. Ypsomed Company Information
Table 101. Ypsomed Description and Business Overview
Table 102. Ypsomed On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Ypsomed On-body Injectors Product
Table 104. Ypsomed Recent Developments/Updates
Table 105. Enable Injections Company Information
Table 106. Enable Injections Description and Business Overview
Table 107. Enable Injections On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Enable Injections On-body Injectors Product
Table 109. Enable Injections Recent Developments/Updates
Table 110. Nemera Company Information
Table 111. Nemera Description and Business Overview
Table 112. Nemera On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Nemera On-body Injectors Product
Table 114. Nemera Recent Developments/Updates
Table 115. Stevanato Group Company Information
Table 116. Stevanato Group Description and Business Overview
Table 117. Stevanato Group On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Stevanato Group On-body Injectors Product
Table 119. Stevanato Group Recent Developments/Updates
Table 120. Sonceboz Company Information
Table 121. Sonceboz Description and Business Overview
Table 122. Sonceboz On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Sonceboz On-body Injectors Product
Table 124. Sonceboz Recent Developments/Updates
Table 125. Lohmann Therapie-Systeme Company Information
Table 126. Lohmann Therapie-Systeme Description and Business Overview
Table 127. Lohmann Therapie-Systeme On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Lohmann Therapie-Systeme On-body Injectors Product
Table 129. Lohmann Therapie-Systeme Recent Developments/Updates
Table 130. Elcam Drug Delivery Devices (E3D) Company Information
Table 131. Elcam Drug Delivery Devices (E3D) Description and Business Overview
Table 132. Elcam Drug Delivery Devices (E3D) On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Elcam Drug Delivery Devices (E3D) On-body Injectors Product
Table 134. Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
Table 135. MicroMED Company Information
Table 136. MicroMED Description and Business Overview
Table 137. MicroMED On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. MicroMED On-body Injectors Product
Table 139. MicroMED Recent Developments/Updates
Table 140. Altek Medical Company Information
Table 141. Altek Medical Description and Business Overview
Table 142. Altek Medical On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Altek Medical On-body Injectors Product
Table 144. Altek Medical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. On-body Injectors Distributors List
Table 148. On-body Injectors Customers List
Table 149. On-body Injectors Market Trends
Table 150. On-body Injectors Market Drivers
Table 151. On-body Injectors Market Challenges
Table 152. On-body Injectors Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of On-body Injectors
Figure 2. Global On-body Injectors Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global On-body Injectors Market Share by Type: 2024 & 2031
Figure 4. Electronic Injectors Product Picture
Figure 5. Mechanical Injectors Product Picture
Figure 6. Global On-body Injectors Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global On-body Injectors Market Share by Application: 2024 & 2031
Figure 8. Immuno-oncology
Figure 9. Cardiovascular Diseases
Figure 10. Neurological Diseases
Figure 11. Others
Figure 12. Global On-body Injectors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global On-body Injectors Market Size (2020-2031) & (US$ Million)
Figure 14. Global On-body Injectors Sales (2020-2031) & (K Units)
Figure 15. Global On-body Injectors Average Price (US$/Unit) & (2020-2031)
Figure 16. On-body Injectors Report Years Considered
Figure 17. On-body Injectors Sales Share by Manufacturers in 2024
Figure 18. Global On-body Injectors Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest On-body Injectors Players: Market Share by Revenue in On-body Injectors in 2024
Figure 20. On-body Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global On-body Injectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America On-body Injectors Sales Market Share by Country (2020-2031)
Figure 23. North America On-body Injectors Revenue Market Share by Country (2020-2031)
Figure 24. United States On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe On-body Injectors Sales Market Share by Country (2020-2031)
Figure 27. Europe On-body Injectors Revenue Market Share by Country (2020-2031)
Figure 28. Germany On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific On-body Injectors Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific On-body Injectors Revenue Market Share by Region (2020-2031)
Figure 35. China On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America On-body Injectors Sales Market Share by Country (2020-2031)
Figure 43. Latin America On-body Injectors Revenue Market Share by Country (2020-2031)
Figure 44. Mexico On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa On-body Injectors Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa On-body Injectors Revenue Market Share by Country (2020-2031)
Figure 49. Turkey On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of On-body Injectors by Type (2020-2031)
Figure 53. Global Revenue Market Share of On-body Injectors by Type (2020-2031)
Figure 54. Global On-body Injectors Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of On-body Injectors by Application (2020-2031)
Figure 56. Global Revenue Market Share of On-body Injectors by Application (2020-2031)
Figure 57. Global On-body Injectors Price (US$/Unit) by Application (2020-2031)
Figure 58. On-body Injectors Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global On-body Injectors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global On-body Injectors Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global On-body Injectors Market Competitive Situation by Manufacturers in 2024
Table 4. Global On-body Injectors Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global On-body Injectors Sales Market Share by Manufacturers (2020-2025)
Table 6. Global On-body Injectors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global On-body Injectors Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market On-body Injectors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of On-body Injectors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of On-body Injectors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of On-body Injectors, Product Type & Application
Table 12. Global Key Manufacturers of On-body Injectors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global On-body Injectors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in On-body Injectors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global On-body Injectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global On-body Injectors Sales by Region (2020-2025) & (K Units)
Table 18. Global On-body Injectors Sales Market Share by Region (2020-2025)
Table 19. Global On-body Injectors Sales by Region (2026-2031) & (K Units)
Table 20. Global On-body Injectors Sales Market Share by Region (2026-2031)
Table 21. Global On-body Injectors Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global On-body Injectors Revenue Market Share by Region (2020-2025)
Table 23. Global On-body Injectors Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global On-body Injectors Revenue Market Share by Region (2026-2031)
Table 25. North America On-body Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America On-body Injectors Sales by Country (2020-2025) & (K Units)
Table 27. North America On-body Injectors Sales by Country (2026-2031) & (K Units)
Table 28. North America On-body Injectors Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America On-body Injectors Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe On-body Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe On-body Injectors Sales by Country (2020-2025) & (K Units)
Table 32. Europe On-body Injectors Sales by Country (2026-2031) & (K Units)
Table 33. Europe On-body Injectors Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe On-body Injectors Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific On-body Injectors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific On-body Injectors Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific On-body Injectors Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific On-body Injectors Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific On-body Injectors Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America On-body Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America On-body Injectors Sales by Country (2020-2025) & (K Units)
Table 42. Latin America On-body Injectors Sales by Country (2026-2031) & (K Units)
Table 43. Latin America On-body Injectors Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America On-body Injectors Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa On-body Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa On-body Injectors Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa On-body Injectors Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa On-body Injectors Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa On-body Injectors Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global On-body Injectors Sales (K Units) by Type (2020-2025)
Table 51. Global On-body Injectors Sales (K Units) by Type (2026-2031)
Table 52. Global On-body Injectors Sales Market Share by Type (2020-2025)
Table 53. Global On-body Injectors Sales Market Share by Type (2026-2031)
Table 54. Global On-body Injectors Revenue (US$ Million) by Type (2020-2025)
Table 55. Global On-body Injectors Revenue (US$ Million) by Type (2026-2031)
Table 56. Global On-body Injectors Revenue Market Share by Type (2020-2025)
Table 57. Global On-body Injectors Revenue Market Share by Type (2026-2031)
Table 58. Global On-body Injectors Price (US$/Unit) by Type (2020-2025)
Table 59. Global On-body Injectors Price (US$/Unit) by Type (2026-2031)
Table 60. Global On-body Injectors Sales (K Units) by Application (2020-2025)
Table 61. Global On-body Injectors Sales (K Units) by Application (2026-2031)
Table 62. Global On-body Injectors Sales Market Share by Application (2020-2025)
Table 63. Global On-body Injectors Sales Market Share by Application (2026-2031)
Table 64. Global On-body Injectors Revenue (US$ Million) by Application (2020-2025)
Table 65. Global On-body Injectors Revenue (US$ Million) by Application (2026-2031)
Table 66. Global On-body Injectors Revenue Market Share by Application (2020-2025)
Table 67. Global On-body Injectors Revenue Market Share by Application (2026-2031)
Table 68. Global On-body Injectors Price (US$/Unit) by Application (2020-2025)
Table 69. Global On-body Injectors Price (US$/Unit) by Application (2026-2031)
Table 70. West Pharmaceutical Services Company Information
Table 71. West Pharmaceutical Services Description and Business Overview
Table 72. West Pharmaceutical Services On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. West Pharmaceutical Services On-body Injectors Product
Table 74. West Pharmaceutical Services Recent Developments/Updates
Table 75. Insulet Company Information
Table 76. Insulet Description and Business Overview
Table 77. Insulet On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Insulet On-body Injectors Product
Table 79. Insulet Recent Developments/Updates
Table 80. Gerresheimer Company Information
Table 81. Gerresheimer Description and Business Overview
Table 82. Gerresheimer On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Gerresheimer On-body Injectors Product
Table 84. Gerresheimer Recent Developments/Updates
Table 85. United Therapeutics Company Information
Table 86. United Therapeutics Description and Business Overview
Table 87. United Therapeutics On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. United Therapeutics On-body Injectors Product
Table 89. United Therapeutics Recent Developments/Updates
Table 90. CC Bio Company Information
Table 91. CC Bio Description and Business Overview
Table 92. CC Bio On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. CC Bio On-body Injectors Product
Table 94. CC Bio Recent Developments/Updates
Table 95. BD Company Information
Table 96. BD Description and Business Overview
Table 97. BD On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. BD On-body Injectors Product
Table 99. BD Recent Developments/Updates
Table 100. Ypsomed Company Information
Table 101. Ypsomed Description and Business Overview
Table 102. Ypsomed On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Ypsomed On-body Injectors Product
Table 104. Ypsomed Recent Developments/Updates
Table 105. Enable Injections Company Information
Table 106. Enable Injections Description and Business Overview
Table 107. Enable Injections On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Enable Injections On-body Injectors Product
Table 109. Enable Injections Recent Developments/Updates
Table 110. Nemera Company Information
Table 111. Nemera Description and Business Overview
Table 112. Nemera On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Nemera On-body Injectors Product
Table 114. Nemera Recent Developments/Updates
Table 115. Stevanato Group Company Information
Table 116. Stevanato Group Description and Business Overview
Table 117. Stevanato Group On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Stevanato Group On-body Injectors Product
Table 119. Stevanato Group Recent Developments/Updates
Table 120. Sonceboz Company Information
Table 121. Sonceboz Description and Business Overview
Table 122. Sonceboz On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Sonceboz On-body Injectors Product
Table 124. Sonceboz Recent Developments/Updates
Table 125. Lohmann Therapie-Systeme Company Information
Table 126. Lohmann Therapie-Systeme Description and Business Overview
Table 127. Lohmann Therapie-Systeme On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Lohmann Therapie-Systeme On-body Injectors Product
Table 129. Lohmann Therapie-Systeme Recent Developments/Updates
Table 130. Elcam Drug Delivery Devices (E3D) Company Information
Table 131. Elcam Drug Delivery Devices (E3D) Description and Business Overview
Table 132. Elcam Drug Delivery Devices (E3D) On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Elcam Drug Delivery Devices (E3D) On-body Injectors Product
Table 134. Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
Table 135. MicroMED Company Information
Table 136. MicroMED Description and Business Overview
Table 137. MicroMED On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. MicroMED On-body Injectors Product
Table 139. MicroMED Recent Developments/Updates
Table 140. Altek Medical Company Information
Table 141. Altek Medical Description and Business Overview
Table 142. Altek Medical On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Altek Medical On-body Injectors Product
Table 144. Altek Medical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. On-body Injectors Distributors List
Table 148. On-body Injectors Customers List
Table 149. On-body Injectors Market Trends
Table 150. On-body Injectors Market Drivers
Table 151. On-body Injectors Market Challenges
Table 152. On-body Injectors Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of On-body Injectors
Figure 2. Global On-body Injectors Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global On-body Injectors Market Share by Type: 2024 & 2031
Figure 4. Electronic Injectors Product Picture
Figure 5. Mechanical Injectors Product Picture
Figure 6. Global On-body Injectors Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global On-body Injectors Market Share by Application: 2024 & 2031
Figure 8. Immuno-oncology
Figure 9. Cardiovascular Diseases
Figure 10. Neurological Diseases
Figure 11. Others
Figure 12. Global On-body Injectors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global On-body Injectors Market Size (2020-2031) & (US$ Million)
Figure 14. Global On-body Injectors Sales (2020-2031) & (K Units)
Figure 15. Global On-body Injectors Average Price (US$/Unit) & (2020-2031)
Figure 16. On-body Injectors Report Years Considered
Figure 17. On-body Injectors Sales Share by Manufacturers in 2024
Figure 18. Global On-body Injectors Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest On-body Injectors Players: Market Share by Revenue in On-body Injectors in 2024
Figure 20. On-body Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global On-body Injectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America On-body Injectors Sales Market Share by Country (2020-2031)
Figure 23. North America On-body Injectors Revenue Market Share by Country (2020-2031)
Figure 24. United States On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe On-body Injectors Sales Market Share by Country (2020-2031)
Figure 27. Europe On-body Injectors Revenue Market Share by Country (2020-2031)
Figure 28. Germany On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific On-body Injectors Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific On-body Injectors Revenue Market Share by Region (2020-2031)
Figure 35. China On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America On-body Injectors Sales Market Share by Country (2020-2031)
Figure 43. Latin America On-body Injectors Revenue Market Share by Country (2020-2031)
Figure 44. Mexico On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa On-body Injectors Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa On-body Injectors Revenue Market Share by Country (2020-2031)
Figure 49. Turkey On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of On-body Injectors by Type (2020-2031)
Figure 53. Global Revenue Market Share of On-body Injectors by Type (2020-2031)
Figure 54. Global On-body Injectors Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of On-body Injectors by Application (2020-2031)
Figure 56. Global Revenue Market Share of On-body Injectors by Application (2020-2031)
Figure 57. Global On-body Injectors Price (US$/Unit) by Application (2020-2031)
Figure 58. On-body Injectors Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232